TIMs, TAMs, and PS- antibody targeting: implications for cancer immunotherapy

TIMs, TAMs, and PS- antibody targeting: implications for cancer immunotherapy

Abstract Immunotherapy for cancer is making impressive strides at improving survival of a subset of cancer patients. To increase the breadth of patients that benefit from immunotherapy, new strategies that combat the immunosuppressive microenvironment of tumors are needed. Phosphatidylserine (PS) si...

Full description

Bibliographic Details
Main Authors: Adam S. Dayoub, Rolf A. Brekken
Format: Article
Language:English
Published: BMC 2020-02-01
Series:Cell Communication and Signaling
Subjects:
Phosphatidylserine
Tumor
TAM
TIM
Antibody
Oncology
Online Access:http://link.springer.com/article/10.1186/s12964-020-0521-5

Internet

http://link.springer.com/article/10.1186/s12964-020-0521-5

Similar Items